Xylem (XYL) Capital Expenditures (2010 - 2026)

Xylem's Capital Expenditures history runs 17 years deep, the most recent figure standing at $90.0 million for Q1 2026.

• On a quarterly basis, Capital Expenditures rose 26.76% year-over-year to $90.0 million in Q1 2026; TTM through Mar 2026 was $193.0 million, a 6.63% increase from a year earlier, with the FY2025 full-year figure at $331.0 million, up 3.12% from the prior year.
• Capital Expenditures climbed to $90.0 million in Q1 2026 per XYL's latest filing, from $83.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $100.0 million in Q4 2024 and bottomed at $3.0 million in Q2 2024.
• The 5-year median for Capital Expenditures is $53.0 million (2022), against an average of $54.5 million.
• Across the five-year window, Capital Expenditures tumbled 94.34% in 2024 and jumped 266.67% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $60.0 million in 2022, then surged by 56.67% to $94.0 million in 2023, then increased by 6.38% to $100.0 million in 2024, then dropped by 17.0% to $83.0 million in 2025, then increased by 8.43% to $90.0 million in 2026.
• Per Business Quant, the three latest XYL Capital Expenditures figures stand at $90.0 million (Q1 2026), $83.0 million (Q4 2025), and $9.0 million (Q3 2025).